Evolent Health Q4 revenue up 54% to $382.4M; new partnerships to add $250M+ in 2024

Evolent Health, Inc.

2022-FY EPS reported -$0.20 revenue$382,432,000

Q4 revenue $382.4M (+54% YoY); net loss $11.3M; Adjusted EBITDA $32.3M (8.4% margin).
Full year 2022 revenue $1,352M (+48.9% YoY); net loss $19.2M; Adjusted EBITDA $106.3M (7.9% margin).
Total Lives on Platform 20.6M as of Dec 31, 2022, up from 17.7M a year ago.
New Performance Suite deal with 5th largest US health insurer for oncology in FL/AZ, expected to drive >$250M revenue in 2024.
New risk-based agreement with large regional health plan within Evolent Care Partners.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Evolent Health, Inc. reported Quarter ended December 31, 2022 results: revenue $382.4 million, net income $11.3 million.

Period: Quarter ended December 31, 2022
Revenue: $382.4 million
Net income: $11.3 million
Result: reported results

Exact text from the filing

Quarter ended December 31, 2022: • Revenue of $382.4 million, an increase of $134.1 million, or 54.0%, from the three months ended December 31, 2021. • Net loss attributable to common shareholders of Evolent Health, Inc. of $11.3 million resulting in a net loss margin of (3.0)%.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Evolent Health, Inc. reported Full year ended December 31, 2022 results: revenue $1,352.0 million, net income $19.2 million.

Period: Full year ended December 31, 2022
Revenue: $1,352.0 million
Net income: $19.2 million
Result: reported results

Exact text from the filing

Full year ended December 31, 2022: • Revenue of $1,352.0 million, an increase of $444.1 million, or 48.9%, from the year ended December 31, 2021. • Net loss attributable to common shareholders of Evolent Health, Inc. of $19.2 million resulting in a net loss margin of (1.4)%.

View on SEC.gov

Browse all earnings releases →

Evolent Health, Inc. filing history →

Source: SEC EDGAR

accession 0001628908-23-000014

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.